q2 earnings per share $0.39.
q2 adjusted earnings per share $0.38.
q2 revenue fell 9.4 percent to $1.23 billion.
qtrly net revenue in critical illness recovery hospital segment increased 12.7% to $520 million.
q2 adjusted earnings per share $0.38 excluding items.
qtrly outpatient rehabilitation volumes and revenues were down 48% and 44% year over year.
qtrly revenue in concentra segment down 39% and 33% year-over-year.
qtrly revenue increased 24% year-over-year on a constant currency basis.
qtrly june occupancy rate of 78% was close to pre-covid levels and exceeded june's last year occupancy of 73%.
q2 revenue $312 million versus refinitiv ibes estimate of $413 million.
qtrly net revenue per patient day increased 7.4 percent to $1,867.
q2 revenue fell 36.2 percent to $167 million.
qtrly net revenues fell 17.8% year over year to $1.2 billion.
compname reports q3 adjusted ebitda of $41.5 million versus $76.1 million.
q2 revenue per visit $106.
qtrly volume and revenue shortfalls in june compared to prior year were 19.7% and 17.8% respectively.
